| |
| |
|
| Insider
Information: |
Hawran Paul W |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
467,578 |
|
|
Indirect Shares
|
132,000 |
|
|
| Direct
Value |
$31,219,382 |
|
|
|
Indirect Value
|
$18,044,400 |
|
|
| Total
Shares |
599,578 |
|
|
| Total
Value |
$49,263,782 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Executive VP and CFO |
2006-05-17 |
228,144 |
2006-05-17 |
132,000 |
Premium* |
|
|
Sequenom Inc |
SQNM |
Chief Financial Officer |
2009-03-13 |
115,888 |
|
0 |
Premium* |
|
|
Plus Therapeutics Inc |
PSTV |
Director |
2015-05-08 |
123,546 |
2009-04-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Executive VP and CFO |
• – – |
2004-02-11 |
4 |
S |
$56.58 |
$566,825 |
D/D |
(10,000) |
105,044 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Executive VP and CFO |
• – – |
2004-03-01 |
4 |
A |
$55.15 |
$55,150 |
D/D |
1,000 |
106,044 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Executive VP and CFO |
• – – |
2005-02-14 |
4 |
A |
$42.78 |
$80,084 |
D/D |
1,872 |
107,916 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Executive VP and CFO |
• – – |
2005-10-27 |
4 |
OE |
$5.38 |
$317,736 |
D/D |
18,915 |
302,244 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Executive VP and CFO |
• – – |
2005-10-27 |
4 |
D |
$51.00 |
$317,730 |
D/D |
(6,230) |
297,014 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
officerTitle |
• – – |
2005-12-19 |
4 |
A |
$61.39 |
$346,669 |
I/I |
5,647 |
257,481 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
officerTitle |
• – – |
2005-12-21 |
4 |
S |
$64.36 |
$646,945 |
D/D |
(10,000) |
247,481 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Executive VP and CFO |
• – – |
2006-05-17 |
4 |
S |
$19.66 |
$1,899,039 |
I/I |
(96,144) |
132,000 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Executive VP and CFO |
• – – |
2006-05-17 |
4 |
S |
$19.85 |
$386,590 |
D/D |
(19,337) |
228,144 |
|
- |
|
| SQNM |
Sequenom Inc |
Chief Financial Officer |
• – – |
2007-05-10 |
4 |
B |
$3.17 |
$31,745 |
D/D |
10,000 |
20,000 |
2.74 |
- |
|
| SQNM |
Sequenom Inc |
Chief Financial Officer |
• – – |
2007-05-11 |
4 |
B |
$3.52 |
$35,150 |
D/D |
10,000 |
30,000 |
2.74 |
- |
|
| SQNM |
Sequenom Inc |
Chief Financial Officer |
• – – |
2007-05-17 |
4 |
B |
$3.57 |
$35,650 |
D/D |
10,000 |
40,000 |
2.74 |
- |
|
| SQNM |
Sequenom Inc |
Chief Financial Officer |
• – – |
2007-05-22 |
4 |
B |
$3.97 |
$39,670 |
D/D |
10,000 |
50,000 |
2.74 |
- |
|
| SQNM |
Sequenom Inc |
Chief Financial Officer |
• – – |
2007-06-01 |
4 |
B |
$4.41 |
$92,262 |
D/D |
20,000 |
70,000 |
2.74 |
- |
|
| SQNM |
Sequenom Inc |
Chief Financial Officer |
• – – |
2007-09-17 |
4/A |
B |
$4.98 |
$49,884 |
D/D |
10,000 |
80,000 |
2.74 |
- |
|
| SQNM |
Sequenom Inc |
Chief Financial Officer |
• – – |
2007-09-17 |
4 |
A |
$4.98 |
$49,884 |
D/D |
10,000 |
80,000 |
0 |
- |
|
| SQNM |
Sequenom Inc |
Chief Financial Officer |
• – – |
2007-11-05 |
4 |
B |
$8.78 |
$88,633 |
D/D |
10,000 |
90,000 |
2.74 |
- |
|
| SQNM |
Sequenom Inc |
Chief Financial Officer |
• – – |
2008-02-26 |
4 |
B |
$7.04 |
$71,537 |
D/D |
10,000 |
100,000 |
2.74 |
- |
|
| SQNM |
Sequenom Inc |
Chief Financial Officer |
• – – |
2009-03-04 |
4 |
B |
$13.45 |
$67,250 |
D/D |
5,000 |
113,888 |
2.74 |
- |
|
| SQNM |
Sequenom Inc |
Chief Financial Officer |
• – – |
2009-03-13 |
4 |
B |
$13.46 |
$26,912 |
D/D |
2,000 |
115,888 |
2.74 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2009-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,316 |
4,316 |
0 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2009-11-12 |
4 |
B |
$3.50 |
$35,000 |
D/D |
10,000 |
14,316 |
2.39 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2009-11-17 |
4 |
B |
$3.98 |
$19,900 |
D/D |
5,000 |
19,316 |
2.39 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2009-11-18 |
4 |
B |
$4.24 |
$84,900 |
D/D |
20,000 |
39,316 |
2.39 |
- |
|
| PSTV |
Plus Therapeutics Inc |
Director |
– • – |
2009-11-24 |
4 |
B |
$4.74 |
$23,700 |
D/D |
5,000 |
44,316 |
2.39 |
- |
|
37 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
